Page last updated: 2024-12-08

mt-45

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

(+,-)-1-cyclohexyl-4-(1,2-diphenylethyl)piperazine: RN given refers to (+-)-isomer; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID431865
SCHEMBL ID11504649
MeSH IDM0454198

Synonyms (27)

Synonym
(+-)-1-cyclohexyl-4-(1,2-diphenylethyl)piperazine
mt 45
ic 6
unii-q2640dpw33
piperazine, 1-cyclohexyl-4-(1,2-diphenylethyl)-, (+-)-
q2640dpw33 ,
52694-55-0
(+,-)-1-cyclohexyl-4-(1,2-diphenylethyl)piperazine
mt-45
ic 6 (analgesic)
1-cyclohexyl-4-(1,2-diphenylethyl)piperazine
nsc 299236
41537-67-1
piperazine, 1-cyclohexyl-4-(1,2-diphenylethyl)-
SCHEMBL11504649
mt 45 [who-dd]
1- cyclohexyl-4-(1,2-diphenylethyl)piperazine
ic-6
AKOS028111434
IGBRRSIHEGCUEN-UHFFFAOYSA-N
1-cyclohexyl-4-(1,2-diphenylethyl)-piperazine
Q6718304
gtpl10724
mt45
1-cyclohexyl-4-[1,2-di(phenyl)ethyl]piperazine
cdep
DTXSID60961800

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (5.88)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's12 (70.59)24.3611
2020's4 (23.53)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 51.06

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index51.06 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.35 (4.65)
Search Engine Demand Index81.80 (26.88)
Search Engine Supply Index2.11 (0.95)

This Compound (51.06)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.00%)6.00%
Case Studies4 (20.00%)4.05%
Observational1 (5.00%)0.25%
Other14 (70.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]